ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Telik

Include trials that are no longer recruiting patients.

5 studies were found.
1.RecruitingCarboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
2.RecruitingStudy of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
3.RecruitingStudy of TLK286 vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Carcinoma
4.RecruitingTLK286 (Telcyta) in Combination with Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small cell lung cancer
5.RecruitingTLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
Condition: Ovarian Neoplasms

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act